Wersäll P - Search Results

1

Diverse effect of cytokine treatment of tumor cells on specific versus non-specific cytotoxicity.

Naganuma H, Halapi E, Masucci G, Hansson M, Wersäll P, Hising C, Venkateswaran S, Mellstedt H, Kiessling R. Naganuma H, et al. Among authors: wersall p. Med Oncol Tumor Pharmacother. 1992;9(1):25-33. doi: 10.1007/BF02989650. Med Oncol Tumor Pharmacother. 1992. PMID: 1341317

2

Therapy of colorectal carcinoma with monoclonal antibodies (MAb17-1A) alone and in combination with granulocyte monocyte-colony stimulating factor (GM-CSF).

Mellstedt H, Frödin JE, Ragnhammar P, Masucci G, Ljungberg A, Hjelm AL, Fagerberg J, Lindemalm C, Osterborg A, Wersäll P, et al. Mellstedt H, et al. Among authors: wersall p. Acta Oncol. 1991;30(8):923-31. doi: 10.3109/02841869109088245. Acta Oncol. 1991. PMID: 1777244

3

Chemotherapy and immunotherapy of colorectal cancer.

Masucci G, Ragnhammar P, Frödin JE, Hjelm AL, Wersäll P, Fagerberg J, Osterborg A, Mellstedt H. Masucci G, et al. Among authors: wersall p. Med Oncol Tumor Pharmacother. 1991;8(3):207-20. doi: 10.1007/BF02987181. Med Oncol Tumor Pharmacother. 1991. PMID: 1803182 Review.

4

The therapeutic use of monoclonal antibodies in colorectal carcinoma.

Mellstedt H, Frödin JE, Masucci G, Ragnhammar P, Fagerberg J, Hjelm AL, Shetye J, Wersäll P, Osterborg A. Mellstedt H, et al. Among authors: wersall p. Semin Oncol. 1991 Oct;18(5):462-77. Semin Oncol. 1991. PMID: 1925633 Review. No abstract available.

5

Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.

Wersäll P, Masucci G, Mellstedt H. Wersäll P, et al. Cancer Immunol Immunother. 1991;33(1):45-9. doi: 10.1007/BF01742527. Cancer Immunol Immunother. 1991. PMID: 2021957 Free PMC article.

6

Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A).

Masucci G, Ragnhammar P, Wersäll P, Mellstedt H. Masucci G, et al. Among authors: wersall p. Cancer Immunol Immunother. 1990;31(4):231-5. doi: 10.1007/BF01789174. Cancer Immunol Immunother. 1990. PMID: 2199042 Free PMC article.

7

Simplified long term large scale production of highly active human LAK cells for therapy.

Wersäll P, Masucci G, Pihlstedt P, Wigzell H, Mellstedt H. Wersäll P, et al. Med Oncol Tumor Pharmacother. 1990;7(4):257-63. doi: 10.1007/BF02987104. Med Oncol Tumor Pharmacother. 1990. PMID: 2283892

8

Generation of human LAK cells in tissue culture bags using recombinant IL-2 and serum free medium. Effects of pretreatment with phenylalanine-methylester.

Wersäll P, Masucci G, Pihlstedt P, Cotgreave I, Tribukait B, Ullberg M, Wigzell H, Mellstedt H. Wersäll P, et al. Acta Oncol. 1990;29(4):431-7. doi: 10.3109/02841869009090026. Acta Oncol. 1990. PMID: 2390269

9

Biologic response modifiers in the treatment of gastrointestinal malignancies.

Mellstedt H, Frödin JE, Lindemalm C, Masucci G, Merk K, Pettersson D, Ragnhammar P, Steinitz M, Wedelin C, Wersäll P, et al. Mellstedt H, et al. Among authors: wersall p. Scand J Gastroenterol. 1989 Apr;24(3):257-68. doi: 10.3109/00365528909093044. Scand J Gastroenterol. 1989. PMID: 2660246 Review. No abstract available.

10

Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.

Masucci G, Wersäll P, Ragnhammar P, Mellstedt H. Masucci G, et al. Among authors: wersall p. Cancer Immunol Immunother. 1989;29(4):288-92. doi: 10.1007/BF00199217. Cancer Immunol Immunother. 1989. PMID: 2665935 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page